NO20061009L - Benzoksazepinforbindelse - Google Patents

Benzoksazepinforbindelse

Info

Publication number
NO20061009L
NO20061009L NO20061009A NO20061009A NO20061009L NO 20061009 L NO20061009 L NO 20061009L NO 20061009 A NO20061009 A NO 20061009A NO 20061009 A NO20061009 A NO 20061009A NO 20061009 L NO20061009 L NO 20061009L
Authority
NO
Norway
Prior art keywords
optionally substituted
ring
bond
lowering activity
formula
Prior art date
Application number
NO20061009A
Other languages
English (en)
Norwegian (no)
Inventor
Shogo Marui
Takashi Miki
Shoutarou Miura
Tomoyuki Nishimoto
Yoshihisa Nakada
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20061009L publication Critical patent/NO20061009L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20061009A 2003-08-01 2006-03-01 Benzoksazepinforbindelse NO20061009L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003285341 2003-08-01
PCT/JP2004/011293 WO2005012272A1 (fr) 2003-08-01 2004-07-30 Compose de benzoxazepine

Publications (1)

Publication Number Publication Date
NO20061009L true NO20061009L (no) 2006-05-02

Family

ID=34113877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061009A NO20061009L (no) 2003-08-01 2006-03-01 Benzoksazepinforbindelse

Country Status (14)

Country Link
US (1) US20080227770A1 (fr)
EP (1) EP1650201A4 (fr)
KR (1) KR20060052906A (fr)
CN (1) CN1832934A (fr)
AU (1) AU2004260757A1 (fr)
BR (1) BRPI0413009A (fr)
CA (1) CA2534464A1 (fr)
IL (1) IL173324A0 (fr)
MX (1) MXPA06001007A (fr)
NO (1) NO20061009L (fr)
RU (1) RU2337100C2 (fr)
TW (1) TW200510356A (fr)
WO (1) WO2005012272A1 (fr)
ZA (1) ZA200600899B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101203243A (zh) * 2005-04-22 2008-06-18 国立大学法人神户大学 黄色瘤治疗药
TW200730503A (en) * 2005-10-21 2007-08-16 Daiichi Seiyaku Co Tricyclic compound
WO2008032696A1 (fr) * 2006-09-12 2008-03-20 Takeda Pharmaceutical Company Limited Agent préventif ou thérapeutique pour une maladie respiratoire
JP2010150142A (ja) * 2007-04-25 2010-07-08 Daiichi Sankyo Co Ltd 三環性ヘテロアリール化合物
WO2010041726A1 (fr) * 2008-10-10 2010-04-15 第一三共株式会社 Composé hétéroarylique tricyclique substitué
CN101891639A (zh) * 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
CN104744491B (zh) * 2009-09-28 2017-07-11 霍夫曼-拉罗奇有限公司 苯并氧杂氮杂*pi3k抑制剂化合物和使用方法
CN108623555B (zh) * 2017-03-17 2021-07-06 中国医学科学院药物研究所 一种苯并氧杂䓬类化合物、及其制备方法和药物组合物与用途
GB202213166D0 (en) 2022-09-08 2022-10-26 Cambridge Entpr Ltd Novel compounds, compositions and therapeutic uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07267939A (ja) * 1994-02-09 1995-10-17 Takeda Chem Ind Ltd 光学活性な４，１−ベンゾオキサゼピン誘導体とその用途
DK0862562T3 (da) * 1995-09-13 2001-09-24 Takeda Chemical Industries Ltd Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
JP3479796B2 (ja) * 1995-09-13 2003-12-15 武田薬品工業株式会社 ベンゾオキサゼピン化合物
US5965553A (en) * 1996-06-20 1999-10-12 Pfizer Inc. Squalene synthetase inhibitors
US20040063750A1 (en) * 2000-11-09 2004-04-01 Tomoyuki Nishimoto High-density lipoprotein-cholesterol level elevating agent
JP4138299B2 (ja) * 2000-11-09 2008-08-27 武田薬品工業株式会社 高密度リポタンパク−コレステロール上昇剤

Also Published As

Publication number Publication date
RU2006106281A (ru) 2006-08-10
WO2005012272A1 (fr) 2005-02-10
MXPA06001007A (es) 2006-04-27
EP1650201A4 (fr) 2009-02-18
CA2534464A1 (fr) 2005-02-10
BRPI0413009A (pt) 2006-10-03
US20080227770A1 (en) 2008-09-18
EP1650201A1 (fr) 2006-04-26
KR20060052906A (ko) 2006-05-19
TW200510356A (en) 2005-03-16
ZA200600899B (en) 2007-04-25
IL173324A0 (en) 2006-06-11
RU2337100C2 (ru) 2008-10-27
AU2004260757A1 (en) 2005-02-10
CN1832934A (zh) 2006-09-13

Similar Documents

Publication Publication Date Title
NO20061009L (no) Benzoksazepinforbindelse
WO2006008250A3 (fr) Derives d'oxime et utilisation comme acides latents
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
ATE357434T1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
SI1742642T1 (sl) Fosfonatni analogi inhibitorskih spojin HIV integraze
NO20061793L (no) 1,4-disubstituerte isoquinilonderlvater som RAF-kinaseinhibitorer nyttige for behandling av proliferative sykdommer
TW200407339A (en) Manufacture method of living radical polymers and the polymers
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
WO2009109991A3 (fr) Nouveaux inhibiteurs de tyrosine kinase contenant de l'hydrazide
CY1110434T1 (el) Παραγωγα ν-πυρρολιδιν-3-υλ-αμιδιου ως αναστολεις επαναπροσληψεως σεροτονινης και νοραδρεναλινης
BRPI0509588A (pt) derivados e tetraidronaftiridina e um processo para preparação dos mesmos
WO2005021025A3 (fr) Modulation de la transcription activee par ?-catenine/tcf
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
BR0313686A (pt) Compostos quìmicos
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
AU2003247279A1 (en) Furancarboxamides
AU4262299A (en) Intermediates for the synthesis of epothilones and methods for their preparation
HUP0301189A2 (hu) Pirazolibifenilkarboxamidok, intermedierjeik, eljárás előállításukra és alkalmazásuk nemkívánatos mikroorganizmusok leküzdésére
WO2003064384A3 (fr) Reactifs sans danger pour l'environnement et procede de trifluoromethylsulfinylation de composes organiques
AU2003232775A1 (en) Oxathiincarboxamides
AU4424401A (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
AU2002339158A1 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
UA84052C2 (ru) Производное кумарина и его применение
AU2003227622A1 (en) Methylthiophene carboxanilides
EE200100295A (et) 1-(aminometüül)tsükloheksüüläädikhappe sünteesi protsess

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application